NeOnc’s Novel Intranasal Approach to Bypassing the Blood Brain Barrier with Therapeutics for CNS Diseases Featured as Cover ...

Glioblastoma, an aggressive form of brain cancer, originates in the brain's supportive tissue, known as glial cells. It is ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Brain Tumor InfoCon will take place on October 8, 2024 from 7:00 PM to 8:00 PM. It will feature six presentations, followed ...

Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A have announced that they have entered into a global ...

Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.

Fibromun, an innovative anti-cancer immunotherapy, is being investigated in registration trials by Philogen for the treatment ...

Sun Pharmaceutical Industries on Tuesday said it has inked a global licensing pact with Italian-Swiss firm Philogen for an ...

Sun Pharma has signed a global licensing deal with Philogen to commercialize Fibromun, an anti-cancer treatment currently in ...

Sun Pharma inks a global licensing agreement with Philogen for Fibromun, an anti-cancer immunotherapy, for the treatment of ...

U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has earned an NIH fast-track ...

Fifteen University of Guelph research projects, as well as state-of-the-art equipment investments key to these studies, will be awarded more than $1.4 million by the federal government.From tackling t ...